NDC 63629-5074 – Buprenorphine HCl and Naloxone HCl

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC63629-5074

Product details

Brand name
Buprenorphine HCl and Naloxone HCl
Generic name
Buprenorphine and Naloxone
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203136
Marketed since
February 22, 2013
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine HCl and Naloxone HCl →

Package NDC codes (10)

Package NDCDescriptionSince
63629-5074-042 TABLET in 1 BOTTLE (63629-5074-0)Apr 2, 2024
63629-5074-130 TABLET in 1 BOTTLE (63629-5074-1)Apr 2, 2024
63629-5074-260 TABLET in 1 BOTTLE (63629-5074-2)Apr 2, 2024
63629-5074-390 TABLET in 1 BOTTLE (63629-5074-3)Apr 2, 2024
63629-5074-4120 TABLET in 1 BOTTLE (63629-5074-4)Apr 2, 2024
63629-5074-514 TABLET in 1 BOTTLE (63629-5074-5)Apr 2, 2024
63629-5074-628 TABLET in 1 BOTTLE (63629-5074-6)Apr 2, 2024
63629-5074-76 TABLET in 1 BOTTLE (63629-5074-7)Apr 2, 2024
63629-5074-810 TABLET in 1 BOTTLE (63629-5074-8)Apr 2, 2024
63629-5074-921 TABLET in 1 BOTTLE (63629-5074-9)Apr 2, 2024

Other Buprenorphine HCl and Naloxone HCl products